CD33 and acute myeloid leukemia: Both CD33GO and CD123 BATs mediated effective and specific cytotoxicity for all AML cell lines with variable CD33 and CD123 expression at E:T ratios ranging from 0.5:1 to 4:1 except NoMo1.